Lansoprazole versus ranitidine for the treatment of reflux oesophagitis. UK Lansoprazole Clinical Research Group

Lansoprazole is a H+.K(+)-ATPase (proton pump) inhibitor with an anti-secretory action and is therefore potentially useful in the treatment of gastro-oesophageal reflux. This study was conducted to determine the efficacy and short-term safety of lansoprazole at doses of 30 mg or 60 mg once daily, co...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Alimentary pharmacology & therapeutics 1995-04, Vol.9 (2), p.145
Hauptverfasser:	Bardhan, K D, Hawkey, C J, Long, R G, Morgan, A G, Wormsley, K G, Moules, I K, Brocklebank, D
Format:	Artikel
Sprache:	eng
Schlagworte:	2-Pyridinylmethylsulfinylbenzimidazoles Adult Aged Double-Blind Method Esophagitis, Peptic - drug therapy Follow-Up Studies H(+)-K(+)-Exchanging ATPase - pharmacology Headache - chemically induced Humans Lansoprazole Male Middle Aged Omeprazole - adverse effects Omeprazole - analogs & derivatives Omeprazole - therapeutic use Proton Pump Inhibitors Ranitidine - adverse effects Ranitidine - therapeutic use Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!